Risk for Lung Cancer Written in the Blood

Diagnostics World | Researchers in London have identified a 14-protein blood signature predictive of lung cancer risk more than five years before a clinical diagnosis. If the proteomics panel makes its way to routine clinical practice, it could prove invaluable in flagging individuals likely to benefit from preventive screening.